dm+d

18548003

Articles

Example medicines to prescribe by brand name in primary care

27 March 2022Prescribe certain medicines by brand to ensure supply of the same product. Examples are grouped by therapeutic area. The list of products is not exhaustive.

Extended-release methylphenidate: A review of the pharmacokinetic profiles of available products

23 December 2020This review discusses current NICE recommendations for the use of methylphenidate for the treatment of ADHD and describes the pharmacokinetic differences between the currently available…

Safety in Lactation: Drugs for ADHD

21 October 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. The use of drugs for attention…
Search Articles

Medicine Compliance Aid Stability

Medikinet XLFlynn Pharma Ltd

Flynn Pharma Ltd
Medikinet XL
Capsules m/r 5mg, 10mg, 20mg, 30mg, 40mg, 50mg, 60mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Protect from moisture. Store in airtight container.
19 August 2022

RitalinNovartis Pharmaceuticals UK Ltd

Novartis Pharmaceuticals UK Ltd
Ritalin
Tablets 10mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from moisture.
19 August 2022

MedikinetFlynn Pharma Ltd

Flynn Pharma Ltd
Medikinet
Tablets 5mg, 10mg, 20mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Unsuitable due to packaging.
19 August 2022

Concerta XLJanssen-Cilag Ltd

Janssen-Cilag Ltd
Concerta XL
Tablets m/r 18mg, 27mg, 36mg, 54mg
R1 · Red 1Stability data indicates that the drug is not suitable for CAs.
Unsuitable
Not suitable for compliance aid - packaged with a desiccant.
19 August 2022

Equasym XLTakeda UK Ltd

Takeda UK Ltd
Equasym XL
Capsules m/r 10mg, 20mg, 30mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special requirements for storage.
19 August 2022

Matoride XLSandoz Ltd

Sandoz Ltd
Matoride XL
Tablets prolonged release f/c 36mg, 54mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Drying plug in bottle, protect from moisture.
19 August 2022

Lactation Safety Information

-
Limited published evidence of safety
Negligible amounts in breast milk
Monitor infant for decreased appetite/weight gain, sleep disturbances, irritability
28 June 2021